首页> 中文期刊> 《转化医学电子杂志》 >肺表面活性物质蛋白B参与新生儿呼吸窘迫综合征发病可能机制的探讨

肺表面活性物质蛋白B参与新生儿呼吸窘迫综合征发病可能机制的探讨

             

摘要

AIM:To explore the possible mechanism of the lung surface active substance protein B (SP-B)in neonatal respiratory distress syndrome (RDS ).METHODS:Selected from Septem-ber 201 1 to September 201 3,63 cases of unrelated newborns dy-ing of RDS were set as RDS group,of which there were 31 weeks or less group,32~36 weeks group and 37 weeks or more group, 21 cases in each group;63 cases of newborn,unrelated,death from other diseases,were set as the control group,to match the gestational age with the RDS group at 1 ∶1 .RESULTS:RDS group,lung SP-BmRNA positive cells number did not increase with the increase of gestational age,whereas the control lung SP-BmRNA positive cells number increased with the increase of ges-tational age.SP-BmRNA positive expression cells in RDS group were obviously lower than the control group.Defect frequency of B protein in RDS group was 1 4.29%,significantly higher than the control group's 1 .59%;RDS group's SP-BmRNA defect frequency was 42.86%,which was also significantly higher than the control group's 7.94%.CONCLUSION:SP-BmRNA defects involved in the pathogenesis of RDS.%目的:探讨肺表面活性物质蛋白B(SP-B)参与新生儿呼吸窘迫综合征(RDS )发病的可能机制.方法:选取我院2011-09/2013-09收治的63例因RDS死亡且无血缘关系的新生儿为RDS组,分为32周以下组、32~36周组及36周以上组,每组各21例;选取我院收治的63例无血缘关系的非RDS而死亡的新生儿为对照组,分组方式与 RDS 组以1∶1相对应.结果:RDS组中,肺部表面活性物质蛋白B(SP-B)mRNA阳性的细胞数量随胎龄增加保持不变,而对照组中,肺部表面活性物质蛋白B(SP-B)mRNA阳性的细胞数量随胎龄增加而升高.RDS组肺部表面活性物质蛋白B(SP-B)mRNA阳性的细胞数水平显著小于对照组.RDS组肺表面活性物质蛋白SP-B缺陷频率为14.29%,明显大于对照组(1.59%);RDS组肺表面活性物质蛋白SP-BmRNA缺陷频率42.86%,也明显大于对照组7.94%.结论:SP-BmRNA的缺失也是引发RDS病的因素之一.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号